SlideShare una empresa de Scribd logo
1 de 18
Competitive target gene regulation by
promoter methylation and miRNA

Y-h. Taguchi, Chuo University
0. What is miRNA?

1. Introduction

2. Promoter Methylation

3. MiRaGE Method

4. Competitive target gene regulation by
promoter methylation and miRNA

5. Conclusion
0. What is miRNA?




・miRNA = microRNA
・non-coding RNA
・regulate (suppress) target gene expression via
either
degradation or translation interruption
of target genes
1. Introduction

Epigenetic gene expression regulation is
current central topics in
genomics/bioinformatics because ….

A) Cell types (development, diseases, tumor
formation etc... ) are often decided by
epigentic regulation

B)Control of epigenetic regulation can alter
cell types (suppression of cancer, induction
of pluripotency....)
Epigenetic gene regulation =
gene expression regulation without modification of DNA
sequences

Example
・promoter methylation
・histon modification
・transcription factor binding to promoter region
・miRNA regulation of target genes.....
      How these two regulate gene expression
      cooperatively is unknown.
2. Promoter Methylation


                           Methylated
                             promoter
                                ⇓
                            expression
                           suppression

                          unmethylated
                            promoter
                                ⇓
                          no expression
                           suppression
3. MiRaGE Method
MiRaGE :
MiRNA Ranking by Gene Expression
                 Promoter Methylation

               considered
               miRNA                   target
 miRNA                                  gene

                                          VS


  target
  gene
                                   significantly
                gene            up/downregulated?
                               hypo/hypermethylated?
                            (t test, Wilcoxon test, KS test)
4. Competitive target gene regulation by
promoter methylation and miRNA
Result 1:
hyper(heypo)methyaletion ⇔ less(more) regulated by miRNAs




             suppressive            suppressive
GSE30653
Nazor KL, Altun G, Lynch C, Tran H et al.
Recurrent variations in DNA methylation in human
pluripotent stem cells and their differentiated
derivatives.
Cell Stem Cell 2012 May 4;10(5):620-34.

numbed of cell lines : 271
Promoter methylation is measured by microarray
methylation:
raw value (raw signal)
β-value (normalized value)

271 cell lines vs 1921 miRNAs = 520591 cases
P-values of miRNA target specific promoter
hypomethylation is computed by MiRaGE method
hypo
Significance : adjusted P-value <0.05
Amount of methylation
                           Number of cases
Statistical tests   Not significant  Significant
     t-test            136054          384537       74%
Wilcoxon rank
                       144572          376019       72%
   sum test
 Kolmogorov-
                       129998          390593       75%
 Smirnov test
                             β-values
                          Number of casess
Statistical tests   Not significant   Significant
     t-test             39390           481201      92%
 Wilcoxon test          45188           475403      91%
    KS test             41952           478639      92%
P-values are highly cell type independent
Mean Pearson's correlation coefficients of P-value between
pairs of cell lines.
 Statistical test       Averaged correlation coefficients
                     Amount of methylation
      t-test                      0.9112043
 Wilcoxon rank                   0.8981256
   sum test
 Kolmogorov-                     0.8263153
 Smirnov test
                         β-values
     t-test                      0.8919359
 Wilcoxon test                   0.8832241
    K-Stest                      0.8257556
Result 2:
Genes with hypomethyaled promoter are
downregulated during cell senescence
Result 3:
Genes with hypomethyaled promoter are
upregulated during differentiation from ES
cell
IMR90 and MRC5 (cell senescence)
BG02 and BG03 (differentiation from ES cell)

P-values of miRNA regulation of targe genes are
computed by MiRaGE method
Correlation coefficients between
        P-vales for promoter hypomethylation
                           and
  P-values of miRNA downregulation of target genes
                      are computed
    Hypomethylation : gene expression : expressive
                         vs
       downregulation of miRNA target genes
miRNA regulation of target genes and promoter
methylation are competitive
Cell senescence   Pm:methy = Pm> vs. Pm:regul = Pm>
                     IMR90
     t test           0.33         0.4        0.41
   P -values       *(<2E-16)        *          *
 Wilcoxon test        0.28         0.35      0.33
   P -values           *            *         *
   K-S test           0.31         0.72      0.61
   P -values           *            *         *
                     MRC5
     t test           0.22         0.23      0.25
   P -values           *            *         *
 Wilcoxon test        0.53         0.76      0.73
   P -values           *            *         *
   K-S test           0.38         0.82      0.67
   P -values           *            *         *
Differentiation   Pm:methy = Pm> vs. Pm:regul = 1− Pm<
                         BG02
     t test              ー0.25         ー0.68   ー0.67
   P -values           *(<2E-16)        *       *
 Wilcoxon test           ー0.13         ー0.52   ー0.53
   P -values             2.4E-9         *       *
   K-S test              ー0.16          ー0.7   ー0.69
   P -values            2.8 E-12         *      *
                         BG03
     t test              ー0.31         ー0.57   ー0.53
   P -values               *            *       *
 Wilcoxon test           ー0.14         ー0.23   ー0.23
   P -values            8.9 E-11        *       *
   K-S test              ー0.14         ー0.21   ー0.19
   P -values            1.3E-10         *       *
Result 4:
 Especially, genes with hypomethylated
 promoters are targeted by miR-548, which
 is primate-specific and generally not
 expressive miRNAs.


Cooperative miRNA regulation with promoter
methylation of target gene may assist miRNA-
548 to regulate target genes.
5. Conclusion

 ・Promoter methylation is related to
 miRNA targeting

 ・Genes with hypo(hyper)methylated
 promoters are more(less) frequently
 targeted by miRNAs

 ・miR-548 targeting specific promoter
 methylation may help miR-548 to regulate
 target genes.

Más contenido relacionado

La actualidad más candente (20)

Brentuximab vedotin .Reem Ibrahim
Brentuximab vedotin .Reem Ibrahim   Brentuximab vedotin .Reem Ibrahim
Brentuximab vedotin .Reem Ibrahim
 
PhD Poster
PhD PosterPhD Poster
PhD Poster
 
2.antitumor antibiotics
2.antitumor antibiotics2.antitumor antibiotics
2.antitumor antibiotics
 
Hauber Final Poster
Hauber Final PosterHauber Final Poster
Hauber Final Poster
 
Cancer epigenetics
Cancer epigenetics Cancer epigenetics
Cancer epigenetics
 
SURF poster
SURF posterSURF poster
SURF poster
 
Cancer chemotherapy
Cancer chemotherapyCancer chemotherapy
Cancer chemotherapy
 
poster final
poster finalposter final
poster final
 
mRNA Targets as anticancer agents.
mRNA Targets as anticancer agents.mRNA Targets as anticancer agents.
mRNA Targets as anticancer agents.
 
Pharmacogenomics
Pharmacogenomics Pharmacogenomics
Pharmacogenomics
 
Cance1
Cance1Cance1
Cance1
 
Antisense oligonucleotide therapy
Antisense oligonucleotide therapyAntisense oligonucleotide therapy
Antisense oligonucleotide therapy
 
TARGETED DRUG DELIVERY IN CANCER
TARGETED DRUG DELIVERY IN CANCERTARGETED DRUG DELIVERY IN CANCER
TARGETED DRUG DELIVERY IN CANCER
 
Stress-Induced Tumorigenesis
Stress-Induced TumorigenesisStress-Induced Tumorigenesis
Stress-Induced Tumorigenesis
 
Interpreting serum protein electrophoresis
Interpreting serum protein electrophoresisInterpreting serum protein electrophoresis
Interpreting serum protein electrophoresis
 
Antibody Drug Conjugates
Antibody Drug ConjugatesAntibody Drug Conjugates
Antibody Drug Conjugates
 
Antibody drug conjugates for cancer
Antibody drug conjugates for cancerAntibody drug conjugates for cancer
Antibody drug conjugates for cancer
 
Pharmacogenetics
PharmacogeneticsPharmacogenetics
Pharmacogenetics
 
Cancer Chemotherapies Final
Cancer Chemotherapies FinalCancer Chemotherapies Final
Cancer Chemotherapies Final
 
Targeted cancer therapy
Targeted cancer therapy Targeted cancer therapy
Targeted cancer therapy
 

Destacado

Dna methylation pattern during development
Dna methylation pattern during developmentDna methylation pattern during development
Dna methylation pattern during developmentBhupendra Bhuppe
 
biochemistry Regulation of gene expression
biochemistry Regulation of gene expressionbiochemistry Regulation of gene expression
biochemistry Regulation of gene expressionPrabesh Raj Jamkatel
 
Семинар ДНК 16/05/2014 Сибэнзим
Семинар ДНК 16/05/2014 СибэнзимСеминар ДНК 16/05/2014 Сибэнзим
Семинар ДНК 16/05/2014 СибэнзимRuslan Titov
 
Integrative Analysis of Gene Expression and Promoter Methylation during Repro...
Integrative Analysis of Gene Expression and Promoter Methylation during Repro...Integrative Analysis of Gene Expression and Promoter Methylation during Repro...
Integrative Analysis of Gene Expression and Promoter Methylation during Repro...Y-h Taguchi
 
Identification of aberrant gene expression associated with aberrant promoter ...
Identification of aberrant gene expression associated with aberrant promoter ...Identification of aberrant gene expression associated with aberrant promoter ...
Identification of aberrant gene expression associated with aberrant promoter ...Y-h Taguchi
 
&lt;마더리스크> biomarkers of methylation
&lt;마더리스크> biomarkers of methylation &lt;마더리스크> biomarkers of methylation
&lt;마더리스크> biomarkers of methylation mothersafe
 
Quatitative assessment of chromatin sturcture
Quatitative assessment of chromatin sturctureQuatitative assessment of chromatin sturcture
Quatitative assessment of chromatin sturctureAmerican Biotechnologist
 
Dna methylation field guide 20130806
Dna methylation field guide 20130806Dna methylation field guide 20130806
Dna methylation field guide 20130806abizarl
 
Genes associated with genotype-specific DNA methylation in squamous cell carc...
Genes associated with genotype-specific DNA methylation in squamous cell carc...Genes associated with genotype-specific DNA methylation in squamous cell carc...
Genes associated with genotype-specific DNA methylation in squamous cell carc...Y-h Taguchi
 
Plegable biología molecular
Plegable biología molecularPlegable biología molecular
Plegable biología molecularserapu
 
In search of tissue specific regulators in periodontium - a bioinformatic ap...
In search of tissue specific regulators in periodontium  - a bioinformatic ap...In search of tissue specific regulators in periodontium  - a bioinformatic ap...
In search of tissue specific regulators in periodontium - a bioinformatic ap...Agnieszka Caruso
 
TINAGL1 and B3GALNT1 are potential therapy target genes to suppress metastasi...
TINAGL1 and B3GALNT1 are potential therapy target genes to suppress metastasi...TINAGL1 and B3GALNT1 are potential therapy target genes to suppress metastasi...
TINAGL1 and B3GALNT1 are potential therapy target genes to suppress metastasi...Y-h Taguchi
 
SFRP1 is a possible candidate for epigenetic therapy in non­small cell lung ...
SFRP1 is a possible candidate for epigenetic  therapy in non­small cell lung ...SFRP1 is a possible candidate for epigenetic  therapy in non­small cell lung ...
SFRP1 is a possible candidate for epigenetic therapy in non­small cell lung ...Y-h Taguchi
 
Possible miRNA coregulation of target genes in brain regions by both differ...
Possible miRNA coregulation of  target genes in brain regions  by both differ...Possible miRNA coregulation of  target genes in brain regions  by both differ...
Possible miRNA coregulation of target genes in brain regions by both differ...Y-h Taguchi
 
Functional And Pathway Analysis 2010
Functional And Pathway Analysis 2010Functional And Pathway Analysis 2010
Functional And Pathway Analysis 2010Stewart MacArthur
 
''Translational Repression and eIF4A2 Activity Are Critical for MicroRNA-Medi...
''Translational Repression and eIF4A2 Activity Are Critical for MicroRNA-Medi...''Translational Repression and eIF4A2 Activity Are Critical for MicroRNA-Medi...
''Translational Repression and eIF4A2 Activity Are Critical for MicroRNA-Medi...Wisdom Deebeke Kate
 

Destacado (20)

Dna methylation pattern during development
Dna methylation pattern during developmentDna methylation pattern during development
Dna methylation pattern during development
 
Micro RNAs
Micro RNAsMicro RNAs
Micro RNAs
 
miRNA & siRNA
miRNA & siRNAmiRNA & siRNA
miRNA & siRNA
 
biochemistry Regulation of gene expression
biochemistry Regulation of gene expressionbiochemistry Regulation of gene expression
biochemistry Regulation of gene expression
 
Семинар ДНК 16/05/2014 Сибэнзим
Семинар ДНК 16/05/2014 СибэнзимСеминар ДНК 16/05/2014 Сибэнзим
Семинар ДНК 16/05/2014 Сибэнзим
 
Integrative Analysis of Gene Expression and Promoter Methylation during Repro...
Integrative Analysis of Gene Expression and Promoter Methylation during Repro...Integrative Analysis of Gene Expression and Promoter Methylation during Repro...
Integrative Analysis of Gene Expression and Promoter Methylation during Repro...
 
Identification of aberrant gene expression associated with aberrant promoter ...
Identification of aberrant gene expression associated with aberrant promoter ...Identification of aberrant gene expression associated with aberrant promoter ...
Identification of aberrant gene expression associated with aberrant promoter ...
 
&lt;마더리스크> biomarkers of methylation
&lt;마더리스크> biomarkers of methylation &lt;마더리스크> biomarkers of methylation
&lt;마더리스크> biomarkers of methylation
 
Quatitative assessment of chromatin sturcture
Quatitative assessment of chromatin sturctureQuatitative assessment of chromatin sturcture
Quatitative assessment of chromatin sturcture
 
Dna methylation field guide 20130806
Dna methylation field guide 20130806Dna methylation field guide 20130806
Dna methylation field guide 20130806
 
Genes associated with genotype-specific DNA methylation in squamous cell carc...
Genes associated with genotype-specific DNA methylation in squamous cell carc...Genes associated with genotype-specific DNA methylation in squamous cell carc...
Genes associated with genotype-specific DNA methylation in squamous cell carc...
 
Plegable biología molecular
Plegable biología molecularPlegable biología molecular
Plegable biología molecular
 
In search of tissue specific regulators in periodontium - a bioinformatic ap...
In search of tissue specific regulators in periodontium  - a bioinformatic ap...In search of tissue specific regulators in periodontium  - a bioinformatic ap...
In search of tissue specific regulators in periodontium - a bioinformatic ap...
 
TINAGL1 and B3GALNT1 are potential therapy target genes to suppress metastasi...
TINAGL1 and B3GALNT1 are potential therapy target genes to suppress metastasi...TINAGL1 and B3GALNT1 are potential therapy target genes to suppress metastasi...
TINAGL1 and B3GALNT1 are potential therapy target genes to suppress metastasi...
 
SFRP1 is a possible candidate for epigenetic therapy in non­small cell lung ...
SFRP1 is a possible candidate for epigenetic  therapy in non­small cell lung ...SFRP1 is a possible candidate for epigenetic  therapy in non­small cell lung ...
SFRP1 is a possible candidate for epigenetic therapy in non­small cell lung ...
 
Possible miRNA coregulation of target genes in brain regions by both differ...
Possible miRNA coregulation of  target genes in brain regions  by both differ...Possible miRNA coregulation of  target genes in brain regions  by both differ...
Possible miRNA coregulation of target genes in brain regions by both differ...
 
Regulation of gene expression -2
Regulation of gene expression -2Regulation of gene expression -2
Regulation of gene expression -2
 
Functional And Pathway Analysis 2010
Functional And Pathway Analysis 2010Functional And Pathway Analysis 2010
Functional And Pathway Analysis 2010
 
Influence of micro-RNAs in Eukaryotic Gene Expression
Influence of micro-RNAs in Eukaryotic Gene ExpressionInfluence of micro-RNAs in Eukaryotic Gene Expression
Influence of micro-RNAs in Eukaryotic Gene Expression
 
''Translational Repression and eIF4A2 Activity Are Critical for MicroRNA-Medi...
''Translational Repression and eIF4A2 Activity Are Critical for MicroRNA-Medi...''Translational Repression and eIF4A2 Activity Are Critical for MicroRNA-Medi...
''Translational Repression and eIF4A2 Activity Are Critical for MicroRNA-Medi...
 

Similar a Competitive target gene regulation by promoter methylation and miRNA

Inference of target gene regulation via miRNAs during cell senescence by MiR...
 Inference of target gene regulation via miRNAs during cell senescence by MiR... Inference of target gene regulation via miRNAs during cell senescence by MiR...
Inference of target gene regulation via miRNAs during cell senescence by MiR...Y-h Taguchi
 
DJSobczynski_Regulus_Internship
DJSobczynski_Regulus_InternshipDJSobczynski_Regulus_Internship
DJSobczynski_Regulus_InternshipDaniel Sobczynski
 
CSUN SYMPOSIUM Final
CSUN SYMPOSIUM Final CSUN SYMPOSIUM Final
CSUN SYMPOSIUM Final Alina Adamian
 
7539 a744 19a8-42c3-a1e8-e3a20045a125
7539 a744 19a8-42c3-a1e8-e3a20045a1257539 a744 19a8-42c3-a1e8-e3a20045a125
7539 a744 19a8-42c3-a1e8-e3a20045a125SaraBarretotovio
 
389 b68b5 72c0-4364-a687-c85bfd929865
389 b68b5 72c0-4364-a687-c85bfd929865389 b68b5 72c0-4364-a687-c85bfd929865
389 b68b5 72c0-4364-a687-c85bfd929865SaraBarretotovio
 
MOLECULAR MARKERS IN NKTL
 MOLECULAR MARKERS IN NKTL MOLECULAR MARKERS IN NKTL
MOLECULAR MARKERS IN NKTLspa718
 
Seminario Biología Molecular
Seminario Biología MolecularSeminario Biología Molecular
Seminario Biología Molecularsofiamartinez148
 
Seminario Biología Molecular
Seminario Biología MolecularSeminario Biología Molecular
Seminario Biología Molecularsofiamartinez148
 
Seminario Biología Molecular
Seminario Biología MolecularSeminario Biología Molecular
Seminario Biología Molecularsofiamartinez148
 
Non coding RNA as targets in drug discovery.pptx
Non coding RNA as targets in drug discovery.pptxNon coding RNA as targets in drug discovery.pptx
Non coding RNA as targets in drug discovery.pptxLijoMani
 
lung cancer biomarkers
lung cancer biomarkerslung cancer biomarkers
lung cancer biomarkersKumar Utsav
 
Poster03
Poster03Poster03
Poster03brandi3
 
Dr. John Svaren - 'Neuropatías periféricas hereditarias'
Dr. John Svaren - 'Neuropatías periféricas hereditarias'Dr. John Svaren - 'Neuropatías periféricas hereditarias'
Dr. John Svaren - 'Neuropatías periféricas hereditarias'Fundación Ramón Areces
 
PROTEOMICS INTRODUCTION AND TECHNIQUES
PROTEOMICS  INTRODUCTION AND TECHNIQUESPROTEOMICS  INTRODUCTION AND TECHNIQUES
PROTEOMICS INTRODUCTION AND TECHNIQUESMuhammad Imran
 

Similar a Competitive target gene regulation by promoter methylation and miRNA (20)

Inference of target gene regulation via miRNAs during cell senescence by MiR...
 Inference of target gene regulation via miRNAs during cell senescence by MiR... Inference of target gene regulation via miRNAs during cell senescence by MiR...
Inference of target gene regulation via miRNAs during cell senescence by MiR...
 
DJSobczynski_Regulus_Internship
DJSobczynski_Regulus_InternshipDJSobczynski_Regulus_Internship
DJSobczynski_Regulus_Internship
 
Seminario Biologia Molecular
Seminario Biologia Molecular Seminario Biologia Molecular
Seminario Biologia Molecular
 
Seminario
SeminarioSeminario
Seminario
 
CSUN SYMPOSIUM Final
CSUN SYMPOSIUM Final CSUN SYMPOSIUM Final
CSUN SYMPOSIUM Final
 
7539 a744 19a8-42c3-a1e8-e3a20045a125
7539 a744 19a8-42c3-a1e8-e3a20045a1257539 a744 19a8-42c3-a1e8-e3a20045a125
7539 a744 19a8-42c3-a1e8-e3a20045a125
 
389 b68b5 72c0-4364-a687-c85bfd929865
389 b68b5 72c0-4364-a687-c85bfd929865389 b68b5 72c0-4364-a687-c85bfd929865
389 b68b5 72c0-4364-a687-c85bfd929865
 
Yasset iso point-cigb-2012
Yasset iso point-cigb-2012Yasset iso point-cigb-2012
Yasset iso point-cigb-2012
 
MOLECULAR MARKERS IN NKTL
 MOLECULAR MARKERS IN NKTL MOLECULAR MARKERS IN NKTL
MOLECULAR MARKERS IN NKTL
 
Seminario Biología Molecular
Seminario Biología MolecularSeminario Biología Molecular
Seminario Biología Molecular
 
Seminario Biología Molecular
Seminario Biología MolecularSeminario Biología Molecular
Seminario Biología Molecular
 
Seminario Biología Molecular
Seminario Biología MolecularSeminario Biología Molecular
Seminario Biología Molecular
 
ATM
ATM ATM
ATM
 
Non coding RNA as targets in drug discovery.pptx
Non coding RNA as targets in drug discovery.pptxNon coding RNA as targets in drug discovery.pptx
Non coding RNA as targets in drug discovery.pptx
 
PD Presentation
PD PresentationPD Presentation
PD Presentation
 
lung cancer biomarkers
lung cancer biomarkerslung cancer biomarkers
lung cancer biomarkers
 
Poster03
Poster03Poster03
Poster03
 
Dr. John Svaren - 'Neuropatías periféricas hereditarias'
Dr. John Svaren - 'Neuropatías periféricas hereditarias'Dr. John Svaren - 'Neuropatías periféricas hereditarias'
Dr. John Svaren - 'Neuropatías periféricas hereditarias'
 
Epigenetics final
Epigenetics finalEpigenetics final
Epigenetics final
 
PROTEOMICS INTRODUCTION AND TECHNIQUES
PROTEOMICS  INTRODUCTION AND TECHNIQUESPROTEOMICS  INTRODUCTION AND TECHNIQUES
PROTEOMICS INTRODUCTION AND TECHNIQUES
 

Más de Y-h Taguchi

Tensor decomposition based and principal component analysis based unsupervise...
Tensor decomposition based and principal component analysis based unsupervise...Tensor decomposition based and principal component analysis based unsupervise...
Tensor decomposition based and principal component analysis based unsupervise...Y-h Taguchi
 
主成分分析を用いた教師なし学習による筋萎縮性側索硬化症とがんの遺伝的関連性の解明
主成分分析を用いた教師なし学習による筋萎縮性側索硬化症とがんの遺伝的関連性の解明主成分分析を用いた教師なし学習による筋萎縮性側索硬化症とがんの遺伝的関連性の解明
主成分分析を用いた教師なし学習による筋萎縮性側索硬化症とがんの遺伝的関連性の解明Y-h Taguchi
 
Tensor decomposition­based unsupervised feature extraction identified the un...
Tensor decomposition­based unsupervised  feature extraction identified the un...Tensor decomposition­based unsupervised  feature extraction identified the un...
Tensor decomposition­based unsupervised feature extraction identified the un...Y-h Taguchi
 
Tensor decomposition ­based unsupervised feature extraction applied to matrix...
Tensor decomposition ­based unsupervised feature extraction applied to matrix...Tensor decomposition ­based unsupervised feature extraction applied to matrix...
Tensor decomposition ­based unsupervised feature extraction applied to matrix...Y-h Taguchi
 
遺伝子発現プロファイルからの 薬剤標的タンパクの統計的推定法の開発
遺伝子発現プロファイルからの 薬剤標的タンパクの統計的推定法の開発遺伝子発現プロファイルからの 薬剤標的タンパクの統計的推定法の開発
遺伝子発現プロファイルからの 薬剤標的タンパクの統計的推定法の開発Y-h Taguchi
 
Identification of Candidate Drugs for Heart Failure using Tensor Decompositio...
Identification of Candidate Drugs for Heart Failure using Tensor Decompositio...Identification of Candidate Drugs for Heart Failure using Tensor Decompositio...
Identification of Candidate Drugs for Heart Failure using Tensor Decompositio...Y-h Taguchi
 
Rectified factor networks for biclustering of omics data
Rectified factor networks for biclustering of omics dataRectified factor networks for biclustering of omics data
Rectified factor networks for biclustering of omics dataY-h Taguchi
 
テンソル分解を用いた教師なし学習による変数選択
テンソル分解を用いた教師なし学習による変数選択テンソル分解を用いた教師なし学習による変数選択
テンソル分解を用いた教師なし学習による変数選択Y-h Taguchi
 
主成分分析を用いた教師なし学習による変数選択を用いたヒストン脱アセチル化酵素阻害剤の機能探索
主成分分析を用いた教師なし学習による変数選択を用いたヒストン脱アセチル化酵素阻害剤の機能探索主成分分析を用いた教師なし学習による変数選択を用いたヒストン脱アセチル化酵素阻害剤の機能探索
主成分分析を用いた教師なし学習による変数選択を用いたヒストン脱アセチル化酵素阻害剤の機能探索Y-h Taguchi
 
『主成分分析を用いた教師なし学習による変数選択』 を用いたデング出血熱原因遺伝子の推定
『主成分分析を用いた教師なし学習による変数選択』 を用いたデング出血熱原因遺伝子の推定『主成分分析を用いた教師なし学習による変数選択』 を用いたデング出血熱原因遺伝子の推定
『主成分分析を用いた教師なし学習による変数選択』 を用いたデング出血熱原因遺伝子の推定Y-h Taguchi
 
miRNA-mRNA相互作用同定を用いた 腎芽腫関連遺伝子の推定
miRNA-mRNA相互作用同定を用いた 腎芽腫関連遺伝子の推定miRNA-mRNA相互作用同定を用いた 腎芽腫関連遺伝子の推定
miRNA-mRNA相互作用同定を用いた 腎芽腫関連遺伝子の推定Y-h Taguchi
 
Principal component analysis based unsupervised feature extraction applied to...
Principal component analysis based unsupervised feature extraction applied to...Principal component analysis based unsupervised feature extraction applied to...
Principal component analysis based unsupervised feature extraction applied to...Y-h Taguchi
 
microRNA-mRNA interaction identification in Wilms tumor using principal compo...
microRNA-mRNA interaction identification in Wilms tumor using principal compo...microRNA-mRNA interaction identification in Wilms tumor using principal compo...
microRNA-mRNA interaction identification in Wilms tumor using principal compo...Y-h Taguchi
 
Comprehensive analysis of transcriptome andmetabolome analysis in Intrahepati...
Comprehensive analysis of transcriptome andmetabolome analysis in Intrahepati...Comprehensive analysis of transcriptome andmetabolome analysis in Intrahepati...
Comprehensive analysis of transcriptome andmetabolome analysis in Intrahepati...Y-h Taguchi
 
主成分分析を用いた教師なし学習による出芽酵母 の時間周期遺伝子発現プロファイルの解析
主成分分析を用いた教師なし学習による出芽酵母 の時間周期遺伝子発現プロファイルの解析主成分分析を用いた教師なし学習による出芽酵母 の時間周期遺伝子発現プロファイルの解析
主成分分析を用いた教師なし学習による出芽酵母 の時間周期遺伝子発現プロファイルの解析Y-h Taguchi
 
PCAを用いた2群の有意差検定
PCAを用いた2群の有意差検定PCAを用いた2群の有意差検定
PCAを用いた2群の有意差検定Y-h Taguchi
 
A cross-species bi-clustering approach to identifying conserved co-regulated ...
A cross-species bi-clustering approach to identifying conserved co-regulated ...A cross-species bi-clustering approach to identifying conserved co-regulated ...
A cross-species bi-clustering approach to identifying conserved co-regulated ...Y-h Taguchi
 
主成分分析を用いた教師なし学習による変数選択法を用いたがんにおけるmRNA-miRNA相互作用のより信頼性のある同定
主成分分析を用いた教師なし学習による変数選択法を用いたがんにおけるmRNA-miRNA相互作用のより信頼性のある同定主成分分析を用いた教師なし学習による変数選択法を用いたがんにおけるmRNA-miRNA相互作用のより信頼性のある同定
主成分分析を用いた教師なし学習による変数選択法を用いたがんにおけるmRNA-miRNA相互作用のより信頼性のある同定Y-h Taguchi
 
Heuristic Principal Component Analysis Based unsupervised Feature Extraction...
Heuristic Principal Component Analysis  Based unsupervised Feature Extraction...Heuristic Principal Component Analysis  Based unsupervised Feature Extraction...
Heuristic Principal Component Analysis Based unsupervised Feature Extraction...Y-h Taguchi
 
Integrating different data types by regularized unsupervised multiple kernel...
Integrating different data types by regularized  unsupervised multiple kernel...Integrating different data types by regularized  unsupervised multiple kernel...
Integrating different data types by regularized unsupervised multiple kernel...Y-h Taguchi
 

Más de Y-h Taguchi (20)

Tensor decomposition based and principal component analysis based unsupervise...
Tensor decomposition based and principal component analysis based unsupervise...Tensor decomposition based and principal component analysis based unsupervise...
Tensor decomposition based and principal component analysis based unsupervise...
 
主成分分析を用いた教師なし学習による筋萎縮性側索硬化症とがんの遺伝的関連性の解明
主成分分析を用いた教師なし学習による筋萎縮性側索硬化症とがんの遺伝的関連性の解明主成分分析を用いた教師なし学習による筋萎縮性側索硬化症とがんの遺伝的関連性の解明
主成分分析を用いた教師なし学習による筋萎縮性側索硬化症とがんの遺伝的関連性の解明
 
Tensor decomposition­based unsupervised feature extraction identified the un...
Tensor decomposition­based unsupervised  feature extraction identified the un...Tensor decomposition­based unsupervised  feature extraction identified the un...
Tensor decomposition­based unsupervised feature extraction identified the un...
 
Tensor decomposition ­based unsupervised feature extraction applied to matrix...
Tensor decomposition ­based unsupervised feature extraction applied to matrix...Tensor decomposition ­based unsupervised feature extraction applied to matrix...
Tensor decomposition ­based unsupervised feature extraction applied to matrix...
 
遺伝子発現プロファイルからの 薬剤標的タンパクの統計的推定法の開発
遺伝子発現プロファイルからの 薬剤標的タンパクの統計的推定法の開発遺伝子発現プロファイルからの 薬剤標的タンパクの統計的推定法の開発
遺伝子発現プロファイルからの 薬剤標的タンパクの統計的推定法の開発
 
Identification of Candidate Drugs for Heart Failure using Tensor Decompositio...
Identification of Candidate Drugs for Heart Failure using Tensor Decompositio...Identification of Candidate Drugs for Heart Failure using Tensor Decompositio...
Identification of Candidate Drugs for Heart Failure using Tensor Decompositio...
 
Rectified factor networks for biclustering of omics data
Rectified factor networks for biclustering of omics dataRectified factor networks for biclustering of omics data
Rectified factor networks for biclustering of omics data
 
テンソル分解を用いた教師なし学習による変数選択
テンソル分解を用いた教師なし学習による変数選択テンソル分解を用いた教師なし学習による変数選択
テンソル分解を用いた教師なし学習による変数選択
 
主成分分析を用いた教師なし学習による変数選択を用いたヒストン脱アセチル化酵素阻害剤の機能探索
主成分分析を用いた教師なし学習による変数選択を用いたヒストン脱アセチル化酵素阻害剤の機能探索主成分分析を用いた教師なし学習による変数選択を用いたヒストン脱アセチル化酵素阻害剤の機能探索
主成分分析を用いた教師なし学習による変数選択を用いたヒストン脱アセチル化酵素阻害剤の機能探索
 
『主成分分析を用いた教師なし学習による変数選択』 を用いたデング出血熱原因遺伝子の推定
『主成分分析を用いた教師なし学習による変数選択』 を用いたデング出血熱原因遺伝子の推定『主成分分析を用いた教師なし学習による変数選択』 を用いたデング出血熱原因遺伝子の推定
『主成分分析を用いた教師なし学習による変数選択』 を用いたデング出血熱原因遺伝子の推定
 
miRNA-mRNA相互作用同定を用いた 腎芽腫関連遺伝子の推定
miRNA-mRNA相互作用同定を用いた 腎芽腫関連遺伝子の推定miRNA-mRNA相互作用同定を用いた 腎芽腫関連遺伝子の推定
miRNA-mRNA相互作用同定を用いた 腎芽腫関連遺伝子の推定
 
Principal component analysis based unsupervised feature extraction applied to...
Principal component analysis based unsupervised feature extraction applied to...Principal component analysis based unsupervised feature extraction applied to...
Principal component analysis based unsupervised feature extraction applied to...
 
microRNA-mRNA interaction identification in Wilms tumor using principal compo...
microRNA-mRNA interaction identification in Wilms tumor using principal compo...microRNA-mRNA interaction identification in Wilms tumor using principal compo...
microRNA-mRNA interaction identification in Wilms tumor using principal compo...
 
Comprehensive analysis of transcriptome andmetabolome analysis in Intrahepati...
Comprehensive analysis of transcriptome andmetabolome analysis in Intrahepati...Comprehensive analysis of transcriptome andmetabolome analysis in Intrahepati...
Comprehensive analysis of transcriptome andmetabolome analysis in Intrahepati...
 
主成分分析を用いた教師なし学習による出芽酵母 の時間周期遺伝子発現プロファイルの解析
主成分分析を用いた教師なし学習による出芽酵母 の時間周期遺伝子発現プロファイルの解析主成分分析を用いた教師なし学習による出芽酵母 の時間周期遺伝子発現プロファイルの解析
主成分分析を用いた教師なし学習による出芽酵母 の時間周期遺伝子発現プロファイルの解析
 
PCAを用いた2群の有意差検定
PCAを用いた2群の有意差検定PCAを用いた2群の有意差検定
PCAを用いた2群の有意差検定
 
A cross-species bi-clustering approach to identifying conserved co-regulated ...
A cross-species bi-clustering approach to identifying conserved co-regulated ...A cross-species bi-clustering approach to identifying conserved co-regulated ...
A cross-species bi-clustering approach to identifying conserved co-regulated ...
 
主成分分析を用いた教師なし学習による変数選択法を用いたがんにおけるmRNA-miRNA相互作用のより信頼性のある同定
主成分分析を用いた教師なし学習による変数選択法を用いたがんにおけるmRNA-miRNA相互作用のより信頼性のある同定主成分分析を用いた教師なし学習による変数選択法を用いたがんにおけるmRNA-miRNA相互作用のより信頼性のある同定
主成分分析を用いた教師なし学習による変数選択法を用いたがんにおけるmRNA-miRNA相互作用のより信頼性のある同定
 
Heuristic Principal Component Analysis Based unsupervised Feature Extraction...
Heuristic Principal Component Analysis  Based unsupervised Feature Extraction...Heuristic Principal Component Analysis  Based unsupervised Feature Extraction...
Heuristic Principal Component Analysis Based unsupervised Feature Extraction...
 
Integrating different data types by regularized unsupervised multiple kernel...
Integrating different data types by regularized  unsupervised multiple kernel...Integrating different data types by regularized  unsupervised multiple kernel...
Integrating different data types by regularized unsupervised multiple kernel...
 

Competitive target gene regulation by promoter methylation and miRNA

  • 1. Competitive target gene regulation by promoter methylation and miRNA Y-h. Taguchi, Chuo University
  • 2. 0. What is miRNA? 1. Introduction 2. Promoter Methylation 3. MiRaGE Method 4. Competitive target gene regulation by promoter methylation and miRNA 5. Conclusion
  • 3. 0. What is miRNA? ・miRNA = microRNA ・non-coding RNA ・regulate (suppress) target gene expression via either degradation or translation interruption of target genes
  • 4. 1. Introduction Epigenetic gene expression regulation is current central topics in genomics/bioinformatics because …. A) Cell types (development, diseases, tumor formation etc... ) are often decided by epigentic regulation B)Control of epigenetic regulation can alter cell types (suppression of cancer, induction of pluripotency....)
  • 5. Epigenetic gene regulation = gene expression regulation without modification of DNA sequences Example ・promoter methylation ・histon modification ・transcription factor binding to promoter region ・miRNA regulation of target genes..... How these two regulate gene expression cooperatively is unknown.
  • 6. 2. Promoter Methylation Methylated promoter ⇓ expression suppression unmethylated promoter ⇓ no expression suppression
  • 7. 3. MiRaGE Method MiRaGE : MiRNA Ranking by Gene Expression Promoter Methylation considered miRNA target miRNA gene VS target gene significantly gene up/downregulated? hypo/hypermethylated? (t test, Wilcoxon test, KS test)
  • 8. 4. Competitive target gene regulation by promoter methylation and miRNA Result 1: hyper(heypo)methyaletion ⇔ less(more) regulated by miRNAs suppressive suppressive
  • 9. GSE30653 Nazor KL, Altun G, Lynch C, Tran H et al. Recurrent variations in DNA methylation in human pluripotent stem cells and their differentiated derivatives. Cell Stem Cell 2012 May 4;10(5):620-34. numbed of cell lines : 271 Promoter methylation is measured by microarray methylation: raw value (raw signal) β-value (normalized value) 271 cell lines vs 1921 miRNAs = 520591 cases P-values of miRNA target specific promoter hypomethylation is computed by MiRaGE method hypo Significance : adjusted P-value <0.05
  • 10. Amount of methylation Number of cases Statistical tests Not significant Significant t-test 136054 384537 74% Wilcoxon rank 144572 376019 72% sum test Kolmogorov- 129998 390593 75% Smirnov test β-values Number of casess Statistical tests Not significant Significant t-test 39390 481201 92% Wilcoxon test 45188 475403 91% KS test 41952 478639 92%
  • 11. P-values are highly cell type independent Mean Pearson's correlation coefficients of P-value between pairs of cell lines. Statistical test Averaged correlation coefficients Amount of methylation t-test 0.9112043 Wilcoxon rank 0.8981256 sum test Kolmogorov- 0.8263153 Smirnov test β-values t-test 0.8919359 Wilcoxon test 0.8832241 K-Stest 0.8257556
  • 12. Result 2: Genes with hypomethyaled promoter are downregulated during cell senescence
  • 13. Result 3: Genes with hypomethyaled promoter are upregulated during differentiation from ES cell
  • 14. IMR90 and MRC5 (cell senescence) BG02 and BG03 (differentiation from ES cell) P-values of miRNA regulation of targe genes are computed by MiRaGE method Correlation coefficients between P-vales for promoter hypomethylation and P-values of miRNA downregulation of target genes are computed Hypomethylation : gene expression : expressive vs downregulation of miRNA target genes miRNA regulation of target genes and promoter methylation are competitive
  • 15. Cell senescence Pm:methy = Pm> vs. Pm:regul = Pm> IMR90 t test 0.33 0.4 0.41 P -values *(<2E-16) * * Wilcoxon test 0.28 0.35 0.33 P -values * * * K-S test 0.31 0.72 0.61 P -values * * * MRC5 t test 0.22 0.23 0.25 P -values * * * Wilcoxon test 0.53 0.76 0.73 P -values * * * K-S test 0.38 0.82 0.67 P -values * * *
  • 16. Differentiation Pm:methy = Pm> vs. Pm:regul = 1− Pm< BG02 t test ー0.25 ー0.68 ー0.67 P -values *(<2E-16) * * Wilcoxon test ー0.13 ー0.52 ー0.53 P -values 2.4E-9 * * K-S test ー0.16 ー0.7 ー0.69 P -values 2.8 E-12 * * BG03 t test ー0.31 ー0.57 ー0.53 P -values * * * Wilcoxon test ー0.14 ー0.23 ー0.23 P -values 8.9 E-11 * * K-S test ー0.14 ー0.21 ー0.19 P -values 1.3E-10 * *
  • 17. Result 4: Especially, genes with hypomethylated promoters are targeted by miR-548, which is primate-specific and generally not expressive miRNAs. Cooperative miRNA regulation with promoter methylation of target gene may assist miRNA- 548 to regulate target genes.
  • 18. 5. Conclusion ・Promoter methylation is related to miRNA targeting ・Genes with hypo(hyper)methylated promoters are more(less) frequently targeted by miRNAs ・miR-548 targeting specific promoter methylation may help miR-548 to regulate target genes.